They may be competitors if CDEX is successful at bring their meth gun to market.
The FirstDefender does not do trace detection, only minuscule detection! LOL
For anything other than trace, I don't believe the meth gun will compete. The FirstDefender has a library of over 1000 signatures and can detect over a million mixtures based on those signatures using some very interesting software.
It appears that once again CDEX is targeting a very niche market IMO- "the same marketing model as with Valimed".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.